Cytokinetics’ pipeline tumble continues after ALS med flops in phase 3 interim look

Cytokinetics’ pipeline tumble continues after ALS med flops in phase 3 interim look

Submitted by admin on April 2, 2023 - 4:00pm
Source: 
Fierce Biotech
News Tags: 
Cytokinetics
ALS
clinical trials
reldesemtiv
Headline: 
Cytokinetics’ pipeline tumble continues after ALS med flops in phase 3 interim look
snippet: 


Cytokinetics will stop treating patients with its ALS drug in a phase 3 trial after the med was found to be no better than placebo in an interim analysis. 

Do Not Allow Advertisers to Use My Personal information